The Natrix Management Team
President & Chief Executive Officer
John Chickosky joined the Natrix Board of Directors in 2010 and was named President and CEO in July 2011. Most recently, he held the position of Chief Commercial Officer and President of the BioSystems Division of Xcellerex, Inc., where he was instrumental in developing and executing the company’s commercial strategy. He brings more than 20 years of senior management experience with life science technology companies. Prior to Xcellerex, he held senior positions at Kendro Laboratory Products (now part of ThermoFisher), where he was Vice President, Global Bioprocessing and Drug Discovery Sales and at CARR Separations, where he was Senior Vice President, Sales and Marketing. Prior to CARR, he served as Vice President of Sales and Marketing at AquaAir, Inc. and at Sepracor, Inc as Vice President, Marketing and Vice President, Business Development.
John holds a Bachelor of Science degree in Electrical Engineering and Computer Science from Santa Clara University and an MBA from St. Mary’s College (California).
Chief Financial Officer
Rob Beveridge joined Natrix as CFO in October 2008. Prior to coming to Natrix, Rob was Chief Financial Officer at Texada Software, Inc., a publicly traded technology company based in Toronto. Rob’s expertise includes all aspects of financial management and reporting, investor relations, public and private market fund raising, M&A, and business operations. He has worked with a variety of technology companies both private and public in North America and around the world.
A native of New Zealand, Rob is a Chartered Accountant and holds a Bachelor of Management Studies (B.M.S.) from Waikato University.
James G. Stout, Ph.D.
Vice President, Process Sciences
Jim Stout joined Natrix Separations in November 2012 as Vice President of Process Sciences. He is responsible for all aspects of process development and science for Natrix hydrogel chromatography membranes, advancements in bioprocess membrane technology, process application development, scale up and technology transfer, customer field applications, and customer technical support. Prior to joining Natrix, Jim established himself as a downstream process and technology leader in the bioprocess industry, with prior Director level positions in Purification Process Development at ImmunoGen, Shire HGT, Amgen and Medarex and group leadership positions at Abbott and Alexion
Jim earned his Ph.D. at the University of Cincinnati, and was an NIH Post-Doctoral Fellow at the University of Cincinnati College of Medicine, Department of Pharmacology & Cell Biophysics. He holds a B.S. in Chemistry from Denison University. Jim is the inventor of record on several U.S. patents, and is co-author of 18 peer-reviewed publications.
Gary Skarja, Ph.D.
Director, Research & Development
Gary Skarja joined Natrix in December 2012 as Director of Research & Development. He is responsible for research & development activities for Natrix materials and products; innovation in materials, devices and deployment methods; intellectual property strategies; and external research partnerships. Gary has held several senior R&D positions in the biomedical industry, including Director, Biomaterials & Devices at the Centre for Commercialization of Regenerative Medicine and Vice President, Research & Chief Operating Officer at Rimon Therapeutics Ltd.
Dr. Skarja earned his Ph.D. in Chemical Engineering at the University of Toronto, and his Masters and Bachelors degrees in Chemical Engineering at McMaster University. His is the author of 9 original peer-reviewed scientific papers and 24 conference papers. He holds two issued patents and 14 patents under review.
Director, Operations & Device Development
Brad joined Natrix in September 2007, and is responsible for manufacturing operations and process development for all Natrix materials, products and systems. Brad brings to Natrix 10 years of engineering and management experience with leading technology firms including Photowatt Technologies, STMicroelectronics, and Nortel Networks.
Brad holds a B.A.Sc. in Chemical Engineering from the University of Ottawa.
Dorian Anderson, Ph.D.
Dorian Anderson joined Natrix in April 2013 as Director of Quality. Dorian has more than 20 years of technical and commercial experience in specialty chemicals/polymers, medical devices and biomaterials with companies such as Dow Corning and Vertellus Specialties. In recent positions he has developed and implemented Quality Management Systems to meet global standards in various industries.
Dorian is a native of the UK and earned his Ph.D. in organic chemistry from the University of Wales, Swansea.